GHRS Competitors & Alternatives
Compare GH Research PLC with similar stocks in the same industry
Biotechnology
GHRS
Main Stock$18.51
Tradestie Score
40
Market Cap
$841.74M
Analyst Upside
+131.7%
Top Competitors
217 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
RCUS
Arcus Biosciences, Inc.
|
$18.18
|
$1.43B | - | 61 | Compare |
|
JANX
Janux Therapeutics, Inc. Common Stock
|
$11.68
|
$1.42B | - | 42 | Compare |
|
SNDX
Syndax Pharmaceuticals, Inc.
|
$9.50
|
$1.35B | - | 58 | Compare |
|
RAPP
Rapport Therapeutics, Inc. Common Stock
|
$26.44
|
$1.32B | - | 48 | Compare |
|
XERS
Xeris Biopharma Holdings, Inc. Common Stock
|
$16.47
|
$1.29B | - | 38 | Compare |
|
STOK
Stoke Therapeutics, Inc. Common Stock
|
$26.55
|
$1.29B | - | 54 | Compare |
|
ARDX
Ardelyx, Inc.
|
$3.13
|
$1.29B | - | 67 | Compare |
|
ZYME
Zymeworks Inc.
|
$27.16
|
$1.28B | 59.4 | 48 | Compare |
|
NUVB
Nuvation Bio Inc.
|
$4.08
|
$1.27B | - | 54 | Compare |
|
CVAC
CureVac N.V. Ordinary Shares
|
$4.66
|
$1.22B | 7.0 | 54 | Compare |
More GHRS Analysis
Data updated: Nov 12, 2026 | Industry: Biotechnology (SIC 2834)
217 stocks in this industry